Clinical Trials Browser

Phase 3 × Small Cell Lung Carcinoma × olaparib × Clear all

NCT04624204 2025-07-02

MK 7339-013

Phase 3 Active not recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Small Cell Lung Carcinoma